Drug induced liver injury: Review with a focus on genetic factors, tissue diagnosis, and treatment options

Tawfik Khoury, Ayman Abu Rmeileh, Liron Yosha, Ariel A. Benson, Saleh Daher, Meir Mizrahi

Research output: Contribution to journalReview articlepeer-review

51 Scopus citations

Abstract

Drug-induced liver injury (DILI) is a rare but potentially life threatening adverse drug reaction. DILI may mimic any morphologic characteristic of acute or chronic liver disease, and the histopathologic features of DILI may be indistinguishable from those of other causes of liver injury, such as acute viral hepatitis. In this review article, we provide an update on causative agents, clinical features, pathogenesis, diagnosis modalities, and outcomes of DILI. In addition, we review results of recently reported genetic studies and updates on pharmacological and invasive treatments.

Original languageEnglish
Pages (from-to)99-108
Number of pages10
JournalJournal of Clinical and Translational Hepatology
Volume3
Issue number2
DOIs
StatePublished - 28 Jun 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015 The Second Affiliated Hospital of Chongqing Medical University.

Keywords

  • DILI
  • Hepatotoxicity
  • Treatment

Fingerprint

Dive into the research topics of 'Drug induced liver injury: Review with a focus on genetic factors, tissue diagnosis, and treatment options'. Together they form a unique fingerprint.

Cite this